Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma

被引:21
|
作者
Hwang, Chungsu [1 ,2 ]
Lee, So Jung [3 ]
Lee, Jung Hee [1 ,2 ]
Kim, Ki Hyung [4 ]
Suh, Dong Soo [4 ]
Kwon, Byung-Su [4 ]
Choi, Kyung Un [3 ]
机构
[1] Pusan Natl Univ, Yangsan Hosp, Dept Pathol, Yangsan 50612, Gyeongsangnam D, South Korea
[2] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan 50612, Gyeongsangnam D, South Korea
[3] Pusan Natl Univ Hosp, Dept Pathol, Busan 602739, South Korea
[4] Pusan Natl Univ Hosp, Dept Obstet & Gynecol, Busan 602739, South Korea
关键词
ovarian cancer; tumor-infiltrating lymphocyte; survival; hematoxylin; eosin; BREAST-CANCER; T-CELLS; CHEMOTHERAPY; SURVIVAL; TILS;
D O I
10.3892/ol.2019.10095
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Studies on tumor-infiltrating lymphocytes (TILs) in epithelial ovarian cancer (EOC) have focused on the clinical significance of inflammatory cells of specific subtypes that are identifiable using immunohistochemistry. However, the subtypes of inflammatory cells that reportedly affect patient survival and prognosis have differed from study to study, and few studies have examined TILs using hematoxylin and eosin (H&E) staining. Therefore, the present study aimed to identify the clinical importance of general stromal TILs in EOC by using H&E staining to apply breast cancer recommendations from the International TILs Working Group 2014 on breast cancer using H&E staining. Stromal TILs in 256 EOC cases from Pusan National University Hospital and 475 cases of high-grade serous carcinoma from The Cancer Genome Atlas dataset were assessed. Stromal TILs were evaluated using H&E-stained slides according to the breast cancer recommendations of the International Working Group 2014, and patients were classified into low and high stromal TIL groups according to their stromal TIL values. The associations of these groups with clinicopathologic factors were assessed, and it was confirmed that group membership correlated with survival and prognosis. According to the (2) assessment, the stromal TIL group was associated with tumor grade. Furthermore, the stromal TIL group was associated with overall survival according to Kaplan-Meier analysis with the log-rank test. Finally, the stromal TIL group was an independent prognostic factor according to univariate and multivariate Cox regression analyses. In cases of EOC, the evaluation of general stromal TILs on H&E-stained slides could be used to predict prognosis.
引用
收藏
页码:4557 / 4565
页数:9
相关论文
共 44 条
  • [1] PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
    Kim, Ki Hyung
    Choi, Kyung Un
    Kim, Ahrong
    Lee, So Jung
    Lee, Jung Hee
    Suh, Dong Soo
    Kwon, Byung-su
    Hwang, Chungsu
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
  • [2] PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
    Ki Hyung Kim
    Kyung Un Choi
    Ahrong Kim
    So Jung Lee
    Jung Hee Lee
    Dong Soo Suh
    Byung-su Kwon
    Chungsu Hwang
    Journal of Ovarian Research, 12
  • [3] The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer
    Li, Jun
    Wang, Jieyu
    Chen, Ruifang
    Bai, Yang
    Lu, Xin
    ONCOTARGET, 2017, 8 (09) : 15621 - 15631
  • [4] Do tumor-infiltrating lymphocytes really indicate favorable prognosis in epithelial ovarian cancer?
    Yildirim, Nuri
    Akman, Levent
    Acar, Kamuran
    Demir, Sibel
    Ozkan, Sultan
    Alan, Nuran
    Zekioglu, Osman
    Terek, M. Cosan
    Ozdemir, Necmettin
    Ozsaran, Aydin
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 215 : 55 - 61
  • [5] Machine Learning Quantification of Intraepithelial Tumor-Infiltrating Lymphocytes as a Significant Prognostic Factor in High-Grade Serous Ovarian Carcinomas
    Machuca-Aguado, Jesus
    Conde-Martin, Antonio Felix
    Alvarez-Munoz, Alejandro
    Rodriguez-Zarco, Enrique
    Polo-Velasco, Alfredo
    Rueda-Ramos, Antonio
    Rendon-Garcia, Rosa
    Rios-Martin, Juan Jose
    Idoate, Miguel A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [6] A high number of stromal tumor-infiltrating lymphocytes is a favorable independent prognostic factor in M0 (stages I-III) esophageal squamous cell carcinoma
    Li, Jing
    Tang, Yang
    Huang, Liu
    Yu, Qianqian
    Hu, Guangyuan
    Zou, Yanmei
    Yuan, Xianglin
    DISEASES OF THE ESOPHAGUS, 2017, 30 (01) : 1 - 7
  • [7] Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer
    Fanale, Daniele
    Dimino, Alessandra
    Pedone, Erika
    Brando, Chiara
    Corsini, Lidia Rita
    Filorizzo, Clarissa
    Fiorino, Alessia
    Lisanti, Maria Chiara
    Magrin, Luigi
    Randazzo, Ugo
    Russo, Tancredi Didier Bazan
    Russo, Antonio
    Bazan, Viviana
    CANCERS, 2022, 14 (18)
  • [8] Prognostic impact of tumor-infiltrating lymphocytes in high grade serous ovarian cancer: a systematic review and meta-analysis
    Hao, Jiatao
    Yu, Hui
    Zhang, Taohong
    An, Ruifang
    Xue, Yan
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [9] PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma
    Chen, Hao
    Molberg, Kyle
    Strickland, Amanda L.
    Castrillon, Diego H.
    Carrick, Kelley
    Jiang, Qingping
    Niu, Shuang
    Rivera-Colon, Glorimar
    Gwin, Katja
    Hinson, Stacy
    Lea, Jayanthi
    Miller, David S.
    Zheng, Wenxin
    Lucas, Elena
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (08) : 1050 - 1060
  • [10] Tumor-infiltrating Immune Cells in H&E-stained Sections of Colorectal Cancer Tissue as a Reasonable Immunological Biomarker
    Matsutani, Shinji
    Shibutani, Masatsune
    Maeda, Kiyoshi
    Nagahara, Hisashi
    Fukuoka, Tatsunari
    Iseki, Yasuhito
    Kashiwagi, Shinichiro
    Tanaka, Hiroaki
    Hirakawa, Kosei
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2018, 38 (12) : 6721 - 6727